CN1371274A - Cosmetic composition - Google Patents
Cosmetic composition Download PDFInfo
- Publication number
- CN1371274A CN1371274A CN00812232A CN00812232A CN1371274A CN 1371274 A CN1371274 A CN 1371274A CN 00812232 A CN00812232 A CN 00812232A CN 00812232 A CN00812232 A CN 00812232A CN 1371274 A CN1371274 A CN 1371274A
- Authority
- CN
- China
- Prior art keywords
- compositions
- skin
- composition
- quaternary ammonium
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/416—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/04—Preparations for care of the skin for chemically tanning the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
Description
技术领域Technical field
本发明涉及一种化妆品组合物。具体地,本发明涉及一种可提供良好的滋润作用、水合作用、皮肤感、皮肤柔软性和/或皮肤光滑性益处并且保护皮肤防止受到紫外线伤害的化妆品组合物。The present invention relates to a cosmetic composition. In particular, the present invention relates to a cosmetic composition that provides good moisturization, hydration, skin feel, skin softness and/or skin smoothness benefits and protects the skin from UV rays.
背景技术 Background technique
皮肤由若干层细胞构成,这些细胞覆盖并保护构成皮肤结构的骨架的角蛋白和胶原纤维蛋白。这些细胞层的最外层称为角质层,已知其由8nm厚细胞层围绕的25nm蛋白束构成。阴离子表面活性剂和有机溶剂一般可穿透角质层膜,并经脱脂作用(即去除角质层中的脂类)破坏皮肤的完整性。这种对皮肤表面局部解剖学结构的破坏作用带来粗糙感,从而最终会令表面活性剂或溶剂与角蛋白发生相互作用,产生刺激作用。许多人的皮肤每天都受到这种伤害。另外,皮肤会因环境因素如暴露于冷空气或风中、机械摩擦、在水中浸泡等而受到伤害。但是,最常见形式的由环境引起的皮肤伤害都与暴露于紫外线辐射,特别是由太阳发出的辐射有关。因此,需要一种缓解或改善这种伤害的方法。The skin is made up of several layers of cells that cover and protect the keratin and collagen fibers that form the backbone of the skin structure. The outermost of these cell layers, called the stratum corneum, is known to consist of 25nm protein bundles surrounded by an 8nm thick cell layer. Anionic surfactants and organic solvents generally penetrate the stratum corneum membrane and disrupt the integrity of the skin by degreasing (ie, removing lipids from the stratum corneum). This disruption of the topographical structure of the skin surface results in roughness, which eventually leads to the interaction of surfactants or solvents with keratin, causing irritation. Many people's skin suffers from this damage every day. In addition, the skin can be damaged by environmental factors such as exposure to cold air or wind, mechanical friction, immersion in water, etc. However, the most common forms of environmentally induced skin damage are associated with exposure to ultraviolet radiation, especially that emitted by the sun. Therefore, need a kind of method that alleviates or improves this injury.
在现有技术中,已经配制出声称可帮助角质层将其屏障和保水功能保持在最佳状态的组合物,尽管皮肤在清洗、工作和娱乐中可能遇到有害作用。希望这样的组合物所具有的性能是它们具有良好的皮肤感、保水作用、滋润作用、吸收性和/或摩擦吸入(rub-in)特征。现有技术的组合物试图通过使用一种或多种“护肤有益成分”来实现这些性能。例如,一种给皮肤带来高滋润作用的方法是在组合物中引入多元醇类保湿剂物质如甘油。但是,多元醇含量高并因此具有高度滋润性的护肤组合物因在涂抹到皮肤上时会有粘腻或粘着感,因而会令消费者感觉不好。另一种给皮肤带来所需的皮肤益处的方法是在皮肤护理组合物中引入如多元醇羧酸酯的润肤物质。但是,这样的组合物会在皮肤感(即它们在皮肤上感觉非常油腻)方面带来不利效果,同时摩擦吸入性、吸收性和残余特性差。In the prior art, compositions have been formulated which claim to help the stratum corneum maintain its barrier and water-retaining functions in optimum condition, despite the detrimental effects the skin may encounter during cleansing, work and play. Desirable properties of such compositions are that they have good skin feel, water retention, moisturizing, absorbency and/or rub-in characteristics. Compositions of the prior art attempt to achieve these properties through the use of one or more "skin care benefit ingredients". For example, one method of imparting high moisturization to the skin is to include in the composition a polyol humectant material such as glycerin. However, skin care compositions that are high in polyols and are therefore highly moisturizing can be perceived by consumers as sticky or sticky when applied to the skin. Another means of imparting desired skin benefits to the skin is to incorporate emollients such as polyol carboxylates into skin care compositions. However, such compositions can be detrimental in terms of skin feel (ie they feel very greasy on the skin) and have poor rubbing, absorbency and residual properties.
现在还发现,护肤有益成分的用量和组合物向皮肤提供有益效果的功效之间存在直接关系。但是,事实上皮肤有益成分的含量越高,与之相关的不利效果的危险性也就越高。因此,到目前为止,需要平衡包含高含量皮肤有益成分的组合物的益处和与这种高含量相关的不利作用。因此,需要包含高含量皮肤有益成分并因此提供高滋润作用和水合作用以及提供杰出的皮肤感、皮肤柔软性和皮肤光滑性益处,但显示低程度的相关的不利作用如油腻性、粘着性或粘腻性的组合物。It has also now been discovered that there is a direct relationship between the amount of skin care benefit ingredient used and the efficacy of the composition to provide the benefit to the skin. In fact, however, the higher the content of skin beneficial ingredients, the higher the risk of adverse effects associated with them. Thus, until now, there has been a need to balance the benefits of compositions comprising high levels of skin benefit ingredients with the adverse effects associated with such high levels. Therefore, there is a need to contain high levels of skin benefit ingredients and thus provide high moisturization and hydration as well as provide outstanding skin feel, skin softness and skin smoothness benefits, but exhibit low levels of associated adverse effects such as greasiness, stickiness or sticky compositions.
已知季铵成分可用于化妆品组合物中。例如参见WO-A-99/27904,WO-A-96/32089和EP-A-789,076。US-A-5,804,205中也公开了声称可提供高度滋润作用而不会留下“粘着的”或“粘腻的”残留物的护肤组合物。组合物含有具有2个16-22个碳原子的烷基的季铵化合物、保湿剂和平均粒径低于50μm的非刺激性的疏水微球。据称疏水聚合微球可明显降低与保湿剂高含量相关的“粘着性”。US-A-5,804,205中的组合物还可以包含低含量的润肤剂如矿脂或矿物油。Quaternary ammonium ingredients are known for use in cosmetic compositions. See eg WO-A-99/27904, WO-A-96/32089 and EP-A-789,076. Skin care compositions are also disclosed in US-A-5,804,205 which claim to provide a high level of moisturisation without leaving a "sticky" or "sticky" residue. The composition contains a quaternary ammonium compound with two alkyl groups of 16-22 carbon atoms, a moisturizing agent and non-irritating hydrophobic microspheres with an average particle diameter of less than 50 μm. The hydrophobic polymeric microspheres are said to significantly reduce the "stickiness" associated with high humectant levels. The compositions of US-A-5,804,205 may also contain low levels of emollients such as petrolatum or mineral oil.
带来防太阳光伤害的保护作用的物质也公知用在化妆品组合物中。参见,例如,EP-A-992455、EP-A-953336、WO-A-97/29735和US-A-5989529,上述所有文件都公开了防晒组合物。但是现有技术的组合物在涂抹时,能够经常使人感到发粘,并且难以抹匀防晒活性物质。Substances which bring about protection against sun damage are also known for use in cosmetic compositions. See, for example, EP-A-992455, EP-A-953336, WO-A-97/29735 and US-A-5989529, all of which disclose sunscreen compositions. However, prior art compositions can often feel sticky when applied and make it difficult to spread the sunscreen active.
现已意外地发现包含至少一种季铵成分和防晒活性物质的组合物能够提供防晒活性物质的平滑、均匀地涂抹,并且与之相关的不利作用低。此外,本发明的组合物能够包含高含量的皮肤有益成分以提供良好的益处如皮肤感、皮肤柔软感和皮肤光滑感,但是显示低程度的不利作用如油腻性、粘着性或粘腻性。It has now surprisingly been found that compositions comprising at least one quaternary ammonium ingredient and a sunscreen active provide smooth, even application of the sunscreen active and have low adverse effects associated therewith. Furthermore, the compositions of the present invention can contain high levels of skin benefit ingredients to provide good benefits such as skin feel, skin softness and skin smoothness, but exhibit low levels of adverse effects such as greasy, sticky or sticky.
尽管不希望受到任何理论的束缚,但相信本发明中的季铵成分能够将防晒活性成分形成小泡并促使它们在皮肤上的沉积,由此确保它们更均匀地应用到皮肤上,而没有通常与这种组合物有关的粘着性/粘腻性。此外,还相信本发明的季铵成分能够将任何保湿剂形成小泡并促使它们沉积在皮肤上。结果是保湿剂均匀地、平滑地施用到皮肤上,而粘着性/粘腻性最小。而且,相信本发明的季铵成分能够乳化润肤剂,以确保润肤剂更均匀地施用到皮肤上并且油腻性/粘着性/粘腻性最小。季铵成分帮助降低防晒剂和/或保湿剂/润肤剂因环境因素如水或摩擦而从皮肤上损失掉。而且,相信季铵成分本身带来护肤益处如良好的滋润作用、良好的皮肤感、良好的皮肤柔软性。While not wishing to be bound by any theory, it is believed that the quaternary ammonium ingredients of the present invention are able to vesicle the sunscreen actives and facilitate their deposition on the skin, thereby ensuring that they are more evenly applied to the skin without the usual Stickiness/stickiness associated with this composition. In addition, it is also believed that the quaternary ammonium ingredients of the present invention are capable of vesicularizing any humectants and promoting their deposition on the skin. The result is an even, smooth application of the moisturizer to the skin with minimal stickiness/stickiness. Furthermore, it is believed that the quaternary ammonium ingredients of the present invention are capable of emulsifying the emollient to ensure more even application of the emollient to the skin with minimal greasiness/stickiness/stickiness. Quaternary ammonium ingredients help reduce the loss of sunscreen and/or moisturizers/emollients from the skin due to environmental factors such as water or friction. Furthermore, it is believed that the quaternary ammonium ingredients themselves confer skin care benefits such as good moisturization, good skin feel, good skin softness.
发明概述Summary of Invention
本发明提供了一种化妆品组合物,该组合物包括:The invention provides a cosmetic composition comprising:
(a)至少一种季铵成分;和(a) at least one quaternary ammonium ingredient; and
(b)至少一种防晒活性物质。(b) at least one sunscreen active.
本发明的组合物带来了防晒益处,同时粘着性或粘腻性低。而且,本发明的组合物能够带来良好的护肤益处和低程度的不利作用如油腻感、粘腻感或粘着性。The compositions of the present invention provide sun protection benefits with low stickiness or stickiness. Furthermore, the compositions of the present invention are capable of delivering good skin care benefits with low levels of adverse effects such as greasy, sticky or sticky feel.
发明详述Detailed description of the invention
本发明的组合物包含至少一种季铵成分和至少一种防晒活性物质。这些成分将在下文进行详细地描述。The compositions of the present invention comprise at least one quaternary ammonium ingredient and at least one sunscreen active. These ingredients will be described in detail below.
本发明的组合物能够用于任意合适的目的。特别地,本发明的组合物适于局部施用于皮肤上。具体地,皮肤护理组合物可以是膏霜(creams)、乳液(lotion)、凝胶等形式。优选本发明的化妆品组合物为水包油型乳剂形式,其中在连续含水相中包含一个或多个油相,每个油相含有单一油性组分或呈混溶或均质形式的油性组分的混合物,但所述的不同油相含有彼此不同的物质或各物质的混合物。The compositions of the invention can be used for any suitable purpose. In particular, the compositions of the invention are suitable for topical application to the skin. Specifically, the skin care compositions may be in the form of creams, lotions, gels, and the like. Preferably, the cosmetic composition of the present invention is in the form of an oil-in-water emulsion comprising one or more oily phases in a continuous aqueous phase, each oily phase containing a single oily component or oily components in miscible or homogeneous form mixtures, but the different oil phases contain different substances or mixtures of substances from each other.
本发明的组合物优选包含小泡(vesicles)。优选,所述小泡包含季铵化合物以及防晒活性物质。The compositions of the invention preferably comprise vesicles. Preferably, the vesicles comprise a quaternary ammonium compound and a sunscreen active.
优选,本发明的组合物含有少于10%(重量),优选少于5%(重量),更优选少于3%(重量),更优选0%(重量)的阴离子表面活性剂。Preferably, the compositions of the present invention contain less than 10% by weight, preferably less than 5% by weight, more preferably less than 3% by weight, more preferably 0% by weight of anionic surfactant.
本发明的组合物优选配制成粘度至少约为1,000mPa.s、优选约为1,000至约300,000mPa.s、更优选约为2,500至约250,000mPa.s、特别是约为5,000至约200,000mPa.s(26.8℃,净相,Brookfield DV-II+锭子CP52/CP41)的产品。季铵成分The compositions of the present invention are preferably formulated to have a viscosity of at least about 1,000 mPa.s, preferably from about 1,000 to about 300,000 mPa.s, more preferably from about 2,500 to about 250,000 mPa.s, especially from about 5,000 to about 200,000 mPa.s (26.8°C, net phase, product of Brookfield DV-II+spindle CP52/CP41). Quaternary Ammonium Ingredients
本发明组合物必须含有至少一种季铵成分。适用于化妆品组合物中的各种季铵成分均适用于此。这里采用的术语“季铵成分”是指含季氮原子的化合物或化合物的混合物,其中季氮原子经一个或多个、优选两个含6个或6个以上碳原子的部分取代。优选用于本发明的季铵成分选自季氮被两个部分取代的那些成分,其中两个部分中每个部分含有10个或10个以上、优选12个或12个以上碳原子。高度优选用于此的季铵成分是可在极性溶剂中形成小泡的那些,其可通过显微镜分析法(采用Nikon Eclipse E800显微镜在60倍放大系数下的偏光显微镜)进行检测。本发明中使用的术语“小泡”是指以封闭的、通常为球形几何形状安排的一个或多个双层,所述的双层包括下述的季铵成分。The compositions of the present invention must contain at least one quaternary ammonium ingredient. Various quaternary ammonium ingredients suitable for use in cosmetic compositions are suitable for use herein. As used herein, the term "quaternary ammonium component" means a compound or mixture of compounds containing a quaternary nitrogen atom which is substituted with one or more, preferably two, moieties containing 6 or more carbon atoms. Preferred quaternary ammonium components for use in the present invention are selected from those wherein the quaternary nitrogen is substituted with two moieties each containing 10 or more, preferably 12 or more, carbon atoms. Highly preferred quaternary ammonium components for use herein are those that form vesicles in polar solvents, which can be detected by microscopic analysis (polarized light microscopy using a Nikon Eclipse E800 microscope at a 60X magnification factor). The term "vesicle" as used herein refers to one or more bilayers arranged in a closed, generally spherical geometry, said bilayers comprising the quaternary ammonium component described below.
优选本发明的组合物中含有至少0.01%(重量)、更优选至少0.1%(重量)、还更优选至少1%(重量)、进一步更优选至少3%(重量)的季铵成分。Preferably the compositions of the present invention contain at least 0.01% by weight, more preferably at least 0.1% by weight, still more preferably at least 1% by weight, even more preferably at least 3% by weight of quaternary ammonium ingredients.
优选用于本发明的季铵成分选自:Preferred quaternary ammonium ingredients for use in the present invention are selected from:
(a)通式(I)所示的季铵化合物: (a) quaternary ammonium compound shown in general formula (I):
其中R1和R2独立地是C1-C4烷基或C1-C4羟烷基或氢原子。R3和R4独立地是约含8至约22个碳原子的烷基或链烯基。X-是与季铵化合物和其它辅剂成分相容的成盐阴离子。wherein R 1 and R 2 are independently C 1 -C 4 alkyl or C 1 -C 4 hydroxyalkyl or a hydrogen atom. R3 and R4 are independently an alkyl or alkenyl group containing from about 8 to about 22 carbon atoms. X - is a salt-forming anion compatible with quaternary ammonium compounds and other adjuvant ingredients.
优选的这类季铵化合物是具有通式(I)的季铵,其中R1和R2是甲基或羟乙基,并且R3和R4是包含至少11个碳原子、优选至少15个碳原子的直链或支链的链烷基或链烯基。Preferred quaternary ammonium compounds of this type are quaternary ammonium compounds of general formula (I), wherein R and R are methyl or hydroxyethyl, and R and R are Straight-chain or branched chain alkyl or alkenyl of carbon atoms.
(b)通式(II)或(III)所示的季铵化合物: (b) quaternary ammonium compounds shown in general formula (II) or (III):
其中每个R5单元独立地选自H、支链或直链的C1-C6烷基、支链或直链的C1-C6羟烷基及其混合物,优选是甲基和羟乙基;每个R6单元独立地为直链或支链C11-C22烷基,直链或支链C11-C22链烯基,及其混合物;X-是可与皮肤护理活性成分和辅剂成分相容的阴离子;m为1-4,优选为2;n为1-4,优选为2,并且Q是选自以下的羰基单元: 和 wherein each R unit is independently selected from H, branched or linear C 1 -C 6 alkyl, branched or linear C 1 -C 6 hydroxyalkyl and mixtures thereof, preferably methyl and hydroxy Ethyl; each R 6 unit is independently a linear or branched C 11 -C 22 alkyl, a linear or branched C 11 -C 22 alkenyl, and mixtures thereof; X - is a skin care active Anion compatible with ingredients and adjuvant ingredients; m is 1-4, preferably 2; n is 1-4, preferably 2, and Q is a carbonyl unit selected from: and
其中R7是H,C1-C4烷基,C1-C4羟烷基及其混合物。Wherein R 7 is H, C 1 -C 4 alkyl, C 1 -C 4 hydroxyalkyl and mixtures thereof.
上述季铵化合物的实例中,单元-QR6含有一般是由甘油三酯源衍生得到的脂肪酰基单元。甘油三酯源优选衍生自牛油、部分氢化的牛油、猪油、部分氢化的猪油、植物油和/或部分氢化的植物油,如低芥酸菜子油,红花油,花生油,菜子油,葵花油,玉米油,大豆油,妥尔油,米糠油等,以及这些油的混合物。In the above examples of quaternary ammonium compounds, the unit -QR 6 contains a fatty acyl unit typically derived from a triglyceride source. The source of triglycerides is preferably derived from tallow, partially hydrogenated tallow, lard, partially hydrogenated lard, vegetable oils and/or partially hydrogenated vegetable oils, such as canola oil, safflower oil, peanut oil, rapeseed oil, Sunflower oil, corn oil, soybean oil, tall oil, rice bran oil, etc., and mixtures of these oils.
上述化合物中的抗衡离子X-可以是任何相容的阴离子,优选是强酸的阴离子,例如氯离子、溴离子、甲基硫酸根、乙基硫酸根、硫酸根、硝酸根等,更优选是氯离子或甲基硫酸根。阴离子也可以但不优选带有双电荷,在这种情况下X-代表半个基团。The counter ion X in the above compound can be any compatible anion, preferably an anion of a strong acid, such as chloride, bromide, methylsulfate, ethylsulfate, sulfate, nitrate, etc., more preferably chlorine ion or methylsulfate. The anion can also, but not preferably, be double charged, in which case X- represents a half group.
本发明优选的季铵化合物是如通式(II)所示的二酯和/或二酰胺季铵化合物(DEQA),二酯和二酰胺,其中羰基Q选自: 和 The preferred quaternary ammonium compound of the present invention is diester and/or diamide quaternary ammonium compound (DEQA) as shown in general formula (II), diester and diamide, wherein carbonyl Q is selected from: and
牛油、低芥酸菜子油和棕榈油是方便且经济的脂肪酰基单元的来源,适于在本发明中用作R6单元。Tallow, canola oil, and palm oil are convenient and economical sources of fatty acyl units suitable for use as R units in the present invention.
抗衡离子X-可以是氯离子、溴离子、甲基硫酸根、甲酸根、硫酸根、硝酸根,及其混合物。实际上阴离子X仅作为带正电荷的季铵化合物的抗衡离子存在。在本发明的范围内并不考虑将其限定为特定的阴离子。The counterion X - can be chloride, bromide, methylsulfate, formate, sulfate, nitrate, and mixtures thereof. In practice the anion X is only present as a counterion to the positively charged quaternary ammonium compound. Limitation to specific anions is not considered within the scope of the present invention.
当在本发明中规定二酯时,其中将包含制备过程中带来的通常存在的单酯和三酯。Where diesters are specified in the present invention, the normally present mono- and triesters brought about during the preparation are to be included.
(c)通式(IV)或(V)所示的季铵化合物: (c) quaternary ammonium compounds shown in general formula (IV) or (V):
其中R9是C15-C21无环的脂族烃基,并且R10是C1-C6烷基或烯基。Wherein R 9 is a C 15 -C 21 acyclic aliphatic hydrocarbon group, and R 10 is a C 1 -C 6 alkyl or alkenyl group.
这类铵化合物的pKa值不超过约4,当在含水溶液中分散时可即时产生阳离子电荷,条件是最终组合物的pH不超过约6。Such ammonium compounds have a pKa value of no more than about 4 and can impart a cationic charge upon dispersion in an aqueous solution, provided that the pH of the final composition does not exceed about 6.
(d)通式(VI)或(VII)所示的季铵化合物: (d) quaternary ammonium compounds shown in general formula (VI) or (VII):
其中R9和R10如上文所定义,R11选自C1-C4烷基和羟烷基。wherein R 9 and R 10 are as defined above, and R 11 is selected from C 1 -C 4 alkyl and hydroxyalkyl.
抗衡离子X-可以是氯离子、溴离子、甲基硫酸根、甲酸根、硫酸根、硝酸根,及其混合物。实际上阴离子X仅作为带正电荷的季铵化合物的抗衡离子存在。本发明范围内并不考虑将其限定为特定的阴离子。The counterion X - can be chloride, bromide, methylsulfate, formate, sulfate, nitrate, and mixtures thereof. In practice the anion X is only present as a counterion to the positively charged quaternary ammonium compound. It is not considered within the scope of the present invention to be limited to a particular anion.
(e)通式(VIII)或(IX)所示的季铵化合物: (e) quaternary ammonium compounds shown in general formula (VIII) or (IX):
其中,n为1-6,R9选自C15-C21无环的脂族烃基,并且R12是C1-C4烷基和羟烷基。Wherein, n is 1-6, R 9 is selected from C 15 -C 21 acyclic aliphatic hydrocarbon groups, and R 12 is C 1 -C 4 alkyl and hydroxyalkyl.
这类铵化合物(VIII)的pKa值不超过约4,当在含水溶液中分散时可在原位产生阳离子电荷,条件是最终组合物的pH不超过约6。Such ammonium compounds (VIII) have a pKa value not exceeding about 4 and can generate cationic charges in situ when dispersed in an aqueous solution, provided that the pH of the final composition does not exceed about 6.
抗衡离子X-(IX)可以是氯离子、溴离子、甲基硫酸根、甲酸根、硫酸根、硝酸根,及其混合物。实际上阴离子X仅作为带正电荷的季铵化合物的抗衡离子存在。本发明范围内并不打算将其限定为特定的阴离子。The counterion X − (IX) can be chloride, bromide, methylsulfate, formate, sulfate, nitrate, and mixtures thereof. In practice the anion X is only present as a counterion to the positively charged quaternary ammonium compound. It is not intended that the scope of the present invention be limited to a particular anion.
(f)通式(X)、(XI)、(XII)或(XIII)所示的二季铵化合物: (f) diquaternary ammonium compound shown in general formula (X), (XI), (XII) or (XIII):
其中R5、R6、Q、n和X-与上述通式(II)和(III)中的定义相同,R13选自C1-C6亚烷基,优选是亚乙基,并且z为0-4。wherein R 5 , R 6 , Q, n and X - are as defined in the above general formulas (II) and (III), R 13 is selected from C 1 -C 6 alkylene, preferably ethylene, and z 0-4.
(g)上述季铵化合物的混合物。(g) Mixtures of the above quaternary ammonium compounds.
优选用于本发明中的季铵成分是上述(b)部分中所描述的那样。具体地,优选如上述通式(II)所示的二酯和/或二酰胺季铵(DEQA)化合物。优选用于本发明中的二酯是在通式(II)所示的化合物中R5、R6、和X-如前所述,并且Q是如下式所示的那些: Preferred quaternary ammonium ingredients for use in the present invention are those described in section (b) above. Specifically, diester and/or diamide quaternary ammonium (DEQA) compounds represented by the above general formula (II) are preferred. Preferred diesters for use in the present invention are those represented by the general formula (II) in which R 5 , R 6 , and X - are as previously described, and Q is those represented by the following formula:
优选用于本发明中的二酰胺是在通式(II)所示的化合物中R5、R6和X-如前所述,并且Q是如下式所示的那些: Preferred diamides for use in the present invention are those represented by the general formula (II) in which R 5 , R 6 and X - are as previously described, and Q is those represented by the following formula:
适用于本发明组合物的优选的季铵化合物的实例是:N,N-二(低芥酸菜子酰基-氧-乙基)-N,N-二甲基氯化铵、N,N-二(低芥酸菜子酰基-氧-乙基)-N-甲基,N-(2-羟乙基)甲基硫酸铵、N,N-二(低芥酸菜子酰基-氧-乙基)-N-甲基,N-(2-羟乙基)氯化铵以及它们的混合物。特别优选用于本发明的是N,N-二(低芥酸菜子酰基-氧-乙基)-N-甲基,N-(2-羟乙基)甲基硫酸铵。Examples of preferred quaternary ammonium compounds suitable for use in the compositions of the present invention are: N,N-bis(lowerucanoyl-oxy-ethyl)-N,N-dimethylammonium chloride, N,N-di (Canolanoyl-oxy-ethyl)-N-methyl, N-(2-hydroxyethyl)ammonium methylsulfate, N,N-di(canolanoyl-oxy-ethyl)- N-methyl, N-(2-hydroxyethyl)ammonium chloride and mixtures thereof. Particularly preferred for use in the present invention is N,N-bis(lowerucanoyl-oxy-ethyl)-N-methyl,N-(2-hydroxyethyl)ammonium methylsulfate.
尽管优选季铵化合物衍生自“低芥酸菜子酰基(canolyl)”脂肪酰基,但其它适用的季铵化合物的实例可衍生自其中上述实例中的“低芥酸菜子酰基”可被下列代替的其它脂肪酰基:“牛油酰基、椰油酰基、棕榈酰基(palmyl)、月桂酰基、油酰基、蓖麻油酰基、硬脂酰基、棕榈酰基(palmityl)”替代,这些对应于衍生这些脂肪酰基单元的甘油三酯源。这些可供选择的脂肪酰基源可包含全饱和,或者优选至少部分不饱和的链。防晒剂While it is preferred that the quaternary ammonium compound be derived from a "canolyl" fatty acyl group, other examples of suitable quaternary ammonium compounds may be derived from other compounds wherein "canolyl" in the above examples may be substituted by Fatty acyl: "tallowoyl, cocoyl, palmityl, lauroyl, oleoyl, ricinoleoyl, stearoyl, palmityl" substitutions, which correspond to the glycerol from which these fatty acyl units are derived sources of triesters. These alternative fatty acyl sources may contain fully saturated, or preferably at least partially unsaturated chains. sunscreen
本发明组合物的第二必要成分是它们包含至少一种防晒活性成分。这些防晒活性成分包括有机化合物及其盐以及无机颗粒物质。尽管不希望受到理论的限制,但相信防晒剂可通过下述的一种或多种机理保护皮肤免受紫外线辐射,所述机理包括:吸收、散射和反射紫外线。这些防晒剂的非限定性实例披露于:美国专利5,087,445(Haffey等人,1992年2月11日授权);美国专利5,073,372(Turner等人,1991年12月17日授权);美国专利5,073,371(Turner等人,1991年12月17日授权);美国专利5,160,731(Sabatelli等人,1992年11月3日授权);美国专利5,138,089(Sabatelli,1992年8月11日授权);美国专利5,041,282(Sabatelli,1991年8月20日授权);美国专利4,999,186(Sabatelli等人,1991年3月12日授权);美国专利4,937,370(Sabatelli,1990年6月26日授权);以及Segarin等人在《化妆品科学与技术》(Cosmetics Science and Technology,第VIII章,189页以下)所述的内容。优选的防晒剂选自:对甲氧基肉桂酸2-乙基己酯、水杨酸辛酯、氰双苯丙烯酸辛酯、羟基甲氧基二苯甲酮、N,N-二甲基氨基苯甲酸2-乙基己酯、对氨基苯甲酸、2-苯基-苯并咪唑-5-磺酸、水杨酸高酯、对甲氧基肉桂酸二乙醇胺、4,4′-甲氧基-叔丁基二苯甲酰甲烷、4-异丙基二苯甲酰甲烷、3-(4-甲基亚苄基)樟脑、3-亚苄基樟脑、4-N,N-二甲氨基苯甲酸与2,4-二羟基二苯酮的酯、4-N,N-二甲氨基苯甲酸与2-羟基-4-(2-羟基乙氧基)二苯酮的酯、4-N,N-二甲氨基苯甲酸与4-羟基二苯甲酰基甲烷的酯、4-N,N-二甲氨基苯甲酸与4-(2-羟基乙氧基)二苯甲酰基甲烷的酯、4-N,N-二(2-乙基己基)-氨基苯甲酸与2,4-二羟基二苯酮的酯、4-N,N-二(2-乙基己基)氨基苯甲酸与2-羟基-4-(2-羟基乙氧基)二苯酮的酯、4-N,N-二(2-乙基己基)氨基苯甲酸与4-羟基二苯甲酰基甲烷的酯、4-N,N-二(2-乙基己基)氨基苯甲酸与4-(2-羟基乙氧基)二苯甲酰基甲烷的酯、4-N,N-(2-乙基己基)甲基氨基苯甲酸与2,4-二羟基二苯酮的酯、4-N,N-(2-乙基己基)甲基氨基苯甲酸与2-羟基-4-(2-羟基乙氧基)二苯酮的酯、4-N,N-(2-乙基己基)甲基氨基苯甲酸与4-羟基二苯甲酰基甲烷的酯、4-N,N-(2-乙基己基)甲基氨基苯甲酸与4-(2-羟基乙氧基)二苯甲酰基甲烷的酯、二氧化钛、氧化锌、氧化铁及其混合物。A second essential ingredient of the compositions of the present invention is that they contain at least one sunscreen active. These sunscreen actives include organic compounds and their salts as well as inorganic particulate materials. While not wishing to be bound by theory, it is believed that sunscreens protect the skin from ultraviolet radiation by one or more of the following mechanisms, including absorbing, scattering and reflecting ultraviolet light. Non-limiting examples of these sunscreens are disclosed in: US Patent 5,087,445 (Haffey et al., issued February 11, 1992); US Patent 5,073,372 (Turner et al., issued December 17, 1991); US Patent 5,073,371 (Turner et al. et al., authorized on December 17, 1991); U.S. Patent 5,160,731 (Sabatelli et al., authorized on November 3, 1992); U.S. Patent 5,138,089 (Sabatelli, authorized on August 11, 1992); August 20, 1991); U.S. Patent 4,999,186 (Sabatelli et al., March 12, 1991); U.S. Patent 4,937,370 (Sabatelli, June 26, 1990); and Segarin et al. Technology" (Cosmetics Science and Technology, Chapter VIII, page 189 below). Preferred sunscreens are selected from the group consisting of: 2-ethylhexyl p-methoxycinnamate, octyl salicylate, octocrylene, hydroxymethoxybenzophenone, N,N-dimethylaminobenzene 2-ethylhexyl formate, p-aminobenzoic acid, 2-phenyl-benzimidazole-5-sulfonic acid, homomenthyl salicylate, diethanolamine p-methoxycinnamate, 4,4'-methoxy Base-tert-butyldibenzoylmethane, 4-isopropyldibenzoylmethane, 3-(4-methylbenzylidene)camphor, 3-benzylidenecamphor, 4-N,N-dimethyl Ester of aminobenzoic acid and 2,4-dihydroxybenzophenone, ester of 4-N,N-dimethylaminobenzoic acid and 2-hydroxy-4-(2-hydroxyethoxy)benzophenone, 4- Ester of N,N-dimethylaminobenzoic acid and 4-hydroxydibenzoylmethane, ester of 4-N,N-dimethylaminobenzoic acid and 4-(2-hydroxyethoxy)dibenzoylmethane , 4-N, N-bis(2-ethylhexyl)-aminobenzoic acid and 2,4-dihydroxybenzophenone ester, 4-N,N-bis(2-ethylhexyl)aminobenzoic acid and Esters of 2-hydroxy-4-(2-hydroxyethoxy)benzophenone, esters of 4-N,N-bis(2-ethylhexyl)aminobenzoic acid and 4-hydroxydibenzoylmethane, 4 -Ester of N,N-di(2-ethylhexyl)aminobenzoic acid and 4-(2-hydroxyethoxy)dibenzoylmethane, 4-N,N-(2-ethylhexyl)methyl Ester of aminobenzoic acid and 2,4-dihydroxybenzophenone, 4-N,N-(2-ethylhexyl)methylaminobenzoic acid and 2-hydroxy-4-(2-hydroxyethoxy)di Esters of benzophenone, esters of 4-N,N-(2-ethylhexyl)methylaminobenzoic acid and 4-hydroxydibenzoylmethane, 4-N,N-(2-ethylhexyl)methyl Esters of aminobenzoic acid and 4-(2-hydroxyethoxy)dibenzoylmethane, titanium dioxide, zinc oxide, iron oxide and mixtures thereof.
更优选用于本发明组合物中的防晒剂选自:N,N-二甲基-对氨基苯甲酸2-乙基己酯、对甲氧基肉桂酸2-乙基己酯、氰双苯丙烯酸辛酯、水杨酸辛酯、水杨酸高酯、对氨基苯甲酸、羟基甲氧基二苯甲酮、2-苯基苯并咪唑-5-磺酸、对甲氧基肉桂酸二乙醇胺、4,4′-甲氧基-叔丁基二苯甲酰基甲烷、4-异丙基二苯甲酰基甲烷、3-(4-甲基亚苄基)樟脑、3-亚苄基樟脑、4-N,N-(2-乙基己基)甲基氨基苯甲酸与4-(2-羟基乙氧基)二苯甲酰基甲烷的酯、二氧化钛、氧化锌、氧化铁及其混合物。More preferred sunscreens for use in the compositions of the present invention are selected from the group consisting of: N,N-dimethyl-p-aminobenzoic acid 2-ethylhexyl, p-methoxycinnamic acid 2-ethylhexyl, cyandiphenyl Octyl Acrylate, Octyl Salicylate, High Menthyl Salicylate, p-Aminobenzoic Acid, Hydroxymethoxybenzophenone, 2-Phenylbenzimidazole-5-sulfonic Acid, p-Methoxycinnamic Acid Di Ethanolamine, 4,4'-methoxy-tert-butyldibenzoylmethane, 4-isopropyldibenzoylmethane, 3-(4-methylbenzylidene)camphor, 3-benzylidenecamphor , esters of 4-N,N-(2-ethylhexyl)methylaminobenzoic acid and 4-(2-hydroxyethoxy)dibenzoylmethane, titanium dioxide, zinc oxide, iron oxide and mixtures thereof.
能够应用的防晒剂的确切用量取决于所选择的防晒剂和所要达到的防晒因子(SPF)值而有所不同。SPF常被用于衡量防晒剂防止产生皮肤红斑的光保护作用。参见Federal Register,43卷,166号,38206-38269页,1978年8月25日。但是,本发明的组合物优选包含0.01-20%、更优选0.1-10%重量的防晒活性成分。任选成分The exact amount of sunscreen that can be used will vary depending on the sunscreen chosen and the Sun Protection Factor (SPF) value to be achieved. SPF is often used to measure the photoprotective effect of sunscreens against skin erythema. See Federal Register, Vol. 43, No. 166, pp. 38206-38269, August 25, 1978. However, the compositions according to the invention preferably comprise from 0.01 to 20%, more preferably from 0.1 to 10%, by weight of sunscreen active ingredient. optional ingredients
本发明组合物中可含有各种任选组分,这些任选成分适于使本发明组合物具有更令人接受的美容或美学特性,或者提供附加的使用效果。这些常用的任选成分是本领域普通技术人员所熟知的。这些任选成分包括各种适用于化妆品的成分,如《CTFA国际化妆品词典和手册》(CTFA InternationalCosmetic Ingredient Dictionary and Handbook),第7版,Wenninger和McEwen编,(化妆品、盥洗用品和香料协会公司,Washington,D.C.,1997))。以下列出了这些任选成分中的某些非限定性实例。皮肤有益成分The compositions of the present invention may contain various optional ingredients suitable to impart more acceptable cosmetic or aesthetic properties to the compositions of the present invention, or to provide additional in-use benefits. These common optional ingredients are well known to those of ordinary skill in the art. These optional ingredients include a variety of ingredients suitable for use in cosmetics, such as CTFA International Cosmetic Ingredient Dictionary and Handbook, 7th Edition, Wenninger and McEwen, eds. (Cosmetic, Toiletry and Fragrance Association, Inc., Washington, D.C., 1997)). Some non-limiting examples of these optional ingredients are listed below. Skin Benefits
特别优选本发明的组合物包含皮肤有益成分。本发明中所用的术语“皮肤有益成分”指的是任何例如给皮肤带来滋润作用、保护作用、皮肤感、皮肤柔软性和/或皮肤平滑性益处的化合物或化合物的混合物。优选的用在本发明中的皮肤有益成分是保湿剂、润肤剂以及它们的混合物。优选,本发明的组合物包含润肤剂和保湿剂。It is particularly preferred that the compositions of the invention comprise skin benefit ingredients. As used herein, the term "skin benefit ingredient" refers to any compound or mixture of compounds that, for example, imparts moisturizing, protective, skin feel, skin softness and/or skin smoothness benefits to the skin. Preferred skin benefit ingredients for use herein are humectants, emollients, and mixtures thereof. Preferably, the compositions of the present invention comprise emollients and humectants.
优选,本发明的组合物包含至少1%重量的皮肤有益成分。更优选,本发明的组合物包含2%-70%,优选5%-60%,更优选10%-55%重量的皮肤有益成分。保湿剂Preferably, the compositions of the present invention comprise at least 1% by weight of skin benefit ingredient. More preferably, the compositions of the present invention comprise from 2% to 70%, preferably from 5% to 60%, more preferably from 10% to 55% by weight of a skin benefit ingredient. moisturizer
特别优选的用在本发明组合物中的任选成分是保湿剂。本发明使用的术语“保湿剂”是指可令皮肤具有保水益处的物质。优选本发明组合物包含至少1%(重量),更优选至少5%(重量),还更优选至少10%(重量),进一步优选至少20%(重量)的保湿剂。A particularly preferred optional ingredient for use in the compositions of the present invention is a humectant. As used herein, the term "humectant" refers to a substance that imparts moisture retention benefits to the skin. Preferably the compositions of the present invention comprise at least 1% by weight, more preferably at least 5% by weight, still more preferably at least 10% by weight, still more preferably at least 20% by weight of humectant.
各种适用于化妆品组合物中的保湿剂均适用于本发明。适用于本发明的保湿剂的非限定性实例披露于WO 98/22085,WO 98/18444和WO 97/01326中。优选用于本发明中的保湿剂选自,但不限于:氨基酸及其衍生物,如脯氨酸和精氨酸天冬氨酸盐,l,3-丁二醇,丙二醇和水,以及海松属植物(codiumtomentosum)提取物,胶原氨基酸或肽,肌酸酐,双甘油,生物多糖胶-1(biosaccharide-1),葡糖胺盐,葡糖醛酸盐,谷氨酸盐,聚乙二醇甘油醚(例如甘油聚氧乙烯醚20),甘油,甘油单丙氧基化物,糖原,己二醇,蜂蜜及其提取物或衍生物,氢化淀粉水解产物,水解粘多糖,肌醇,角蛋白氨基酸,脲,LAREX A-200(购自Larex),糖胺聚糖,甲氧基PEG-10,甲基gluceth-10和-20(均可购自Amerchol,位于Edison,NJ),甲基葡萄糖,3-甲基-1,3-丁二醇,N-乙酰基葡糖胺盐,聚乙二醇及其衍生物(如PEG15丁二醇,PEG4,PEG5季戊四醇,PEG6,PEG8,PEG9),季戊四醇,1,2-戊二醇,PPG-1甘油醚,PPG-9,2-吡咯烷酮-5-羧酸及其盐如甘油基PCA,糖异构化物,SEACARE(购自Secma),丝胶蛋白,丝氨基酸,乙酰基透明质酸钠,透明质酸钠,聚天冬氨酸钠,聚谷氨酸钠,sorbeth20,sorbeth6,糖和糖醇、及其衍生物如葡萄糖,甘露糖和聚甘油山梨醇,海藻糖,三甘油,三羟甲基丙烷,三(羟甲基)氨基甲烷盐,酵母提取物,以及它们的混合物。A wide variety of humectants suitable for use in cosmetic compositions are suitable for use in the present invention. Non-limiting examples of humectants suitable for use in the present invention are disclosed in WO 98/22085, WO 98/18444 and WO 97/01326. Preferred humectants for use in the present invention are selected from, but not limited to, amino acids and their derivatives, such as proline and arginine aspartate, 1,3-butanediol, propylene glycol and water, and sea pine Codium tomentosum extract, collagen amino acid or peptide, creatinine, diglycerin, biopolysaccharide-1 (biosaccharide-1), glucosamine salt, glucuronate, glutamate, polyethylene glycol Glyceryl ethers (e.g. glycerol ethoxylate 20), glycerin, glycerol monopropoxylate, glycogen, hexanediol, honey and its extracts or derivatives, hydrogenated starch hydrolysates, hydrolyzed mucopolysaccharides, inositol, horn Proteoaminoglycans, urea, LAREX A-200 (available from Larex), glycosaminoglycans, methoxy PEG-10, methylgluceth-10 and -20 (both available from Amerchol in Edison, NJ), methyl Glucose, 3-methyl-1,3-butanediol, N-acetylglucosamine salt, polyethylene glycol and its derivatives (such as PEG15 butanediol, PEG4, PEG5 pentaerythritol, PEG6, PEG8, PEG9) , pentaerythritol, 1,2-pentanediol, PPG-1 glyceryl ether, PPG-9, 2-pyrrolidone-5-carboxylic acid and its salts such as glyceryl PCA, sugar isomers, SEACARE (available from Secma), silk Glutin, silk amino acid, sodium acetyl hyaluronate, sodium hyaluronate, sodium polyaspartate, sodium polyglutamate, sorbeth20, sorbeth6, sugars and sugar alcohols, and their derivatives such as glucose, mannose and Polyglyceryl sorbitol, trehalose, triglycerin, trimethylolpropane, tris(hydroxymethyl)aminomethane salt, yeast extract, and mixtures thereof.
更优选,用于本发明的保湿剂选自:甘油,脲,丁二醇,聚乙二醇及其衍生物,以及它们的混合物。还更优选,用于本发明的保湿剂选自:甘油、脲和它们的混合物,特别是甘油。润肤剂More preferably, the humectant used in the present invention is selected from the group consisting of glycerin, urea, butylene glycol, polyethylene glycol and derivatives thereof, and mixtures thereof. Even more preferably, the humectant used in the present invention is selected from the group consisting of glycerin, urea and mixtures thereof, especially glycerin. emollient
本发明组合物中另一高度优选的任选成分是润肤剂(emollient)。润肤剂用于润滑皮肤、增进皮肤的光滑性和柔软性,预防或缓解皮肤干燥,并且/或者保护皮肤。已知存在各种适用的润肤剂,并且均可以用在本发明中。Sagarin所著的《化妆品科学与技术》(Cosmetics,Science and Technology)(第2版,第1卷,32-43页(1972))中包括了许多适于用作润肤剂的物质的实例。优选本发明的组合物包含大于1%(重量)的润肤剂,更优选至少为5%(重量),还更优选至少为10%(重量)的润肤剂。Another highly preferred optional ingredient in the compositions of the present invention is an emollient. Emollients are used to lubricate the skin, improve the smoothness and suppleness of the skin, prevent or relieve dryness of the skin, and/or protect the skin. A wide variety of suitable emollients are known and can be used in the present invention. Cosmetics, Science and Technology by Sagarin, 2nd ed., Vol. 1, pp. 32-43 (1972) contains many examples of materials suitable for use as emollients. Preferably the compositions of the present invention comprise greater than 1% by weight of emollient, more preferably at least 5% by weight, still more preferably at least 10% by weight of emollient.
优选适用于此的润肤剂选自:Emollients preferably suitable for use herein are selected from:
i)含约7至约40个碳原子的直链和支链烃,如十二烷、角鲨烷、矿脂、胆甾醇和它们的衍生物,氢化聚异丁烯、异十六烷和C7-C40异链烷烃(为C7-C40支链烃)。i) straight and branched chain hydrocarbons containing from about 7 to about 40 carbon atoms, such as dodecane, squalane, petrolatum, cholesterol and their derivatives, hydrogenated polyisobutene, isohexadecane and C7 -C 40 isoparaffins (being C 7 -C 40 branched chain hydrocarbons).
ii)C1-C30羧酸和C2-C30二元羧酸的C1-C30醇酯,例如异壬酸异壬酯,肉豆蔻酸异丙酯,丙酸肉豆蔻酯,硬脂酸异丙酯,二十二烷酸二十二烷醇酯,马来酸二辛酯,己二酸二异丙酯以及二亚油酸二异丙酯。ii) C 1 -C 30 alcohol esters of C 1 -C 30 carboxylic acids and C 2 -C 30 dicarboxylic acids, such as isononyl isononanoate, isopropyl myristate, myristyl propionate, hard Isopropyl fatty acid, behenyl behenate, dioctyl maleate, diisopropyl adipate, and diisopropyl dilinoleate.
iii)C1-C30羧酸的单甘油酯、二甘油酯和三甘油酯及其乙氧基化衍生物。适用的甘油酯的聚乙二醇衍生物包括:PEG-20杏仁甘油酯,PEG-60杏仁甘油酯,PEG-11鳄梨甘油酯,PEG-6辛/癸酸甘油酯,PEG-8辛/癸酸甘油酯,PEG-20玉米甘油酯,PEG-60玉米甘油酯,PEG-60月见草油甘油酯,PEG-7甘油基椰油酯,PEG-30甘油基椰油酯,PEG-40甘油基椰油酯,PEG-78甘油基椰油酯,PEG-80甘油基椰油酯,PEG-12甘油基二油酸酯,PEG-15甘油基异硬脂酸酯,PEG-20甘油基异硬脂酸酯,PEG-30甘油基异硬脂酸酯,PEG-75可可脂甘油酯,PEG-20氢化棕榈油甘油酯,PEG-70芒果甘油酯,PEG-13貂油甘油酯,PEG-75娑罗双树脂甘油酯,PEG 10橄榄油甘油酯,PEG-12棕榈仁油甘油酯,PEG-45棕榈仁油甘油酯,PEG-8甘油基月桂酸酯和PEG-30甘油基月桂酸酯。甘油酯的聚乙二醇衍生物的混合物也可用于本发明中。iii) Mono-, diglycerides and triglycerides of C 1 -C 30 carboxylic acids and their ethoxylated derivatives. Suitable polyethylene glycol derivatives of glycerides include: PEG-20 Almond Glycerides, PEG-60 Almond Glycerides, PEG-11 Avocado Glycerides, PEG-6 Caprylic/Capric Glycerides, PEG-8 Caprylic/Capric Glycerides Glyceryl Caprate, PEG-20 Corn Glycerides, PEG-60 Corn Glycerides, PEG-60 Evening Primrose Oil Glycerides, PEG-7 Glyceryl Cocoate, PEG-30 Glyceryl Cocoate, PEG-40 Glyceryl Cocoate, PEG-78 Glyceryl Cocoate, PEG-80 Glyceryl Cocoate, PEG-12 Glyceryl Dioleate, PEG-15 Glyceryl Isostearate, PEG-20 Glyceryl Isostearate, PEG-30 Glyceryl Isostearate, PEG-75 Cocoa Butter Glycerides, PEG-20 Hydrogenated Palm Glycerides, PEG-70 Mango Glycerides, PEG-13 Mink Glycerides, PEG -75 Bisporin Glycerides, PEG 10 Olive Glycerides, PEG-12 Palm Kernel Glycerides, PEG-45 Palm Kernel Glycerides, PEG-8 Glyceryl Laurate and PEG-30 Glyceryl Laurate ester. Mixtures of polyethylene glycol derivatives of glycerides may also be used in the present invention.
iv)C1-C30羧酸的亚烷基二醇酯,例如C1-C30羧酸的乙二醇单酯和二酯,以及丙二醇单酯和二酯,例如二硬脂酸乙二醇酯。iv) Alkylene glycol esters of C 1 -C 30 carboxylic acids, such as ethylene glycol monoesters and diesters of C 1 -C 30 carboxylic acids, and propylene glycol monoesters and diesters, such as ethylene glycol distearate alcohol esters.
v)有机聚硅氧烷油。有机聚硅氧烷油可以是挥发性的、非挥发性的或挥发性和非挥发性聚硅氧烷的混合物。本文中使用的术语“非挥发性的”是指在环境条件下为液体,并且闪点(1个大气压下)大于或等于约100℃的那些聚硅氧烷。本文中使用的术语“挥发性的”是指所有其它的聚硅氧烷油。适用的有机聚硅氧烷油可选自跨越较宽范围的挥发性和粘度的各种聚硅氧烷。优选非挥发性聚硅氧烷。适用的聚硅氧烷披露于美国专利5,069,897(1991年12月3日授权)。优选用于本发明的有机聚硅氧烷选自聚烷基硅氧烷、烷基取代的聚二甲基硅氧烷、聚二甲基硅氧烷醇(dimethiconols)、聚烷芳基硅氧烷及其混合物。更优选用于本发明的是聚烷基硅氧烷和环聚二甲基硅氧烷(cyclomethicones)。聚烷基硅氧烷中优选的是聚二甲基硅氧烷。v) Organopolysiloxane oils. The organopolysiloxane oil can be a volatile, nonvolatile or a mixture of volatile and nonvolatile silicones. As used herein, the term "nonvolatile" refers to those polysiloxanes which are liquids at ambient conditions and have a flash point (at 1 atmosphere) of greater than or equal to about 100°C. The term "volatile" as used herein refers to all other silicone oils. Suitable organopolysiloxane oils can be selected from a wide variety of polysiloxanes spanning a wide range of volatilities and viscosities. Non-volatile polysiloxanes are preferred. Suitable polysiloxanes are disclosed in US Patent 5,069,897 (issued December 3, 1991). The organopolysiloxanes preferably used in the present invention are selected from the group consisting of polyalkylsiloxanes, alkyl-substituted polydimethylsiloxanes, dimethiconols, polyalkylarylsiloxanes alkanes and their mixtures. More preferred for use herein are polyalkylsiloxanes and cyclomethicones. Preferred among the polyalkylsiloxanes are polydimethylsiloxanes.
vi)植物油和氢化植物油。植物油和氢化植物油的实例包括:红花油、蓖麻油、椰子油、棉籽油、鲱油、棕榈仁油、棕榈油、花生油、大豆油、菜子油、亚麻子油、米糠油、松油、芝麻油、葵花油、上述来源的油的部分氢化和全氢化形式,以及它们的混合物。vi) Vegetable oils and hydrogenated vegetable oils. Examples of vegetable and hydrogenated vegetable oils include: safflower oil, castor oil, coconut oil, cottonseed oil, menhaden oil, palm kernel oil, palm oil, peanut oil, soybean oil, rapeseed oil, linseed oil, rice bran oil, pine oil, sesame oil , sunflower oil, partially hydrogenated and fully hydrogenated forms of oils from the above sources, and mixtures thereof.
vii)动物油脂,例如鳕鱼肝油、羊毛脂及其衍生物,如乙酰化的羊毛脂和羊毛酸异丙酯。优选羊毛脂油。vii) Animal fats and fats, such as cod liver oil, lanolin and its derivatives, such as acetylated lanolin and isopropyl lanolate. Lanolin oil is preferred.
viii)可以使用的还有聚丙二醇的C4-C20烷基醚、聚丙二醇的C1-C20羧酸酯以及二-C8-C30烷基醚,实例包括PPG-14丁基醚、PPG-15硬脂基醚、二辛基醚、十二烷基辛基醚及其混合物。viii) Also C 4 -C 20 alkyl ethers of polypropylene glycol, C 1 -C 20 carboxylic acid esters of polypropylene glycol and di-C 8 -C 30 alkyl ethers can be used, examples include PPG-14 butyl ether , PPG-15 stearyl ether, dioctyl ether, dodecyl octyl ether and mixtures thereof.
ix)羧酸多元醇酯。ix) Polyol carboxylic acid esters.
x)上述成分的混合物。x) Mixtures of the above ingredients.
优选用于本发明组合物中的润肤剂选自:十二烷、角鲨烷、胆甾醇及其衍生物、异十六烷、异壬酸异壬酯、矿脂、羊毛脂及其衍生物、红花油、蓖麻油、椰子油、棉籽油、棕榈仁油、棕榈油、花生油、大豆油、羧酸多元醇酯以及它们的混合物。更优选用于本发明的润肤剂选自羧酸多元醇酯、矿脂以及它们的混合物。Preferred emollients for use in the compositions of the present invention are selected from the group consisting of dodecane, squalane, cholesterol and its derivatives, isohexadecane, isononyl isononanoate, petrolatum, lanolin and its derivatives. plant, safflower oil, castor oil, coconut oil, cottonseed oil, palm kernel oil, palm oil, peanut oil, soybean oil, polyol carboxylic acid esters, and mixtures thereof. More preferred emollients for use herein are selected from polyol carboxylic acid esters, petrolatum, and mixtures thereof.
这些酯衍生自糖或多元醇部分和一种或多种羧酸部分。取决于构成酯的酸和糖,这些酯在室温条件下可以是液体或固体形式。液体酯的实例包括:四油酸葡糖酯、(不饱和)大豆油脂肪酸的葡糖四酯、混和的大豆油脂肪酸的甘露糖四酯、油酸的半乳糖四酯、亚油酸的阿拉伯糖四酯、木糖四亚油酸酯、五油酸半乳糖酯、四油酸山梨糖醇酯、不饱和大豆油脂肪酸山梨醇六酯、五油酸木糖醇酯、四油酸蔗糖酯、五油酸蔗糖酯、六油酸蔗糖酯、七油酸蔗糖酯、八油酸蔗糖酯及其混合物。固体酯的实例包括:山梨醇六酯,其中的羧酸酯部分是摩尔比为1∶2的棕榈油酸酯和花生酸酯;棉子糖八酯,其中的羧酸酯部分是摩尔比为1∶3的亚油酸酯和二十二烷酸酯;麦芽糖七酯,其中酯化羧酸部分是摩尔比为3∶4的葵花油脂肪酸和二十四烷酸酯;蔗糖的八酯,其中酯化羧酸部分是摩尔比为2∶6的油酸酯和二十二烷酸酯;以及蔗糖的八酯,其中酯化羧酸部分是摩尔比为1∶3∶4的月桂酸酯、亚油酸酯和二十二烷酸酯。优选的固体物质是蔗糖聚酯,其中酯化度为7-8,其中的脂肪酸部分是C18单-和/或二-不饱和酸和二十二烷酸,其中不饱和酸和二十二烷酸的摩尔比为1∶7-3∶5。特别优选的固体糖聚酯是蔗糖的八酯,其中分子中含约7个二十二碳脂肪酸部分和约1个油酸部分。其它物质包括棉籽油或大豆油脂肪酸蔗糖酯。这些酯类物质还披露于美国专利2,831,854;美国专利4,005,196(Jandacek,1977年1月25日授权);美国专利4,005,195(Jandacek,1977年1月25日授权),美国专利5,306,516(Letton等人,1994年4月26日授权);美国专利5,306,515(Letton等人,1994年4月26日授权);美国专利5,305,514(Letton等人,1994年4月26日授权);美国专利4,797,300(Jandacek等人,1989年1月10日授权);美国专利3,963,699(Rizzi等人,1976年6月15日授权);美国专利4,518,772(Volpenhein,1985年5月21日授权);以及美国专利4,517,360(Volpenhein,1985年5月21日授权)。These esters are derived from a sugar or polyol moiety and one or more carboxylic acid moieties. Depending on the acids and sugars from which the esters are composed, these esters can be in liquid or solid form at room temperature. Examples of liquid esters include: glucose tetraoleate, glucose tetraester of (unsaturated) soy fatty acid, mannose tetraester of mixed soy fatty acid, galactose tetraester of oleic acid, arabic acid tetraester of linoleic acid Sugar tetraester, xylose tetralinoleate, galactose pentaoleate, sorbitan tetraoleate, unsaturated soybean oil fatty acid sorbitan hexaester, xylitol pentaoleate, sucrose tetraoleate , sucrose pentaoleate, sucrose hexaoleate, sucrose heptaoleate, sucrose octaoleate and mixtures thereof. Examples of solid esters include: sorbitan hexaester, wherein the carboxylate moiety is palm oleic acid ester and arachidic acid ester in a molar ratio of 1:2; raffinose octaester, wherein the carboxylate moiety is 1:3 linoleate and behenate; maltose heptaester, wherein the esterified carboxylic acid moiety is sunflower fatty acid and behenate in a molar ratio of 3:4; octaester of sucrose, wherein the esterified carboxylic acid moiety is oleate and behenate in a molar ratio of 2:6; and octaester of sucrose wherein the esterified carboxylic acid moiety is laurate in a molar ratio of 1:3:4 , linoleate and behenate. The preferred solid material is sucrose polyester, wherein the degree of esterification is 7-8, wherein the fatty acid moieties are C 18 mono- and/or di-unsaturated acids and behenic acid, wherein the unsaturated acids and behenic acid The molar ratio of alkanoic acid is 1:7-3:5. A particularly preferred solid sugar polyester is the octaester of sucrose having about 7 behenic fatty acid moieties and about 1 oleic acid moiety in the molecule. Other materials include cottonseed oil or soybean oil fatty acid sucrose esters. These esters are also disclosed in U.S. Patent 2,831,854; U.S. Patent 4,005,196 (Jandacek, authorized on January 25, 1977); April 26, 1994); U.S. Patent 5,306,515 (Letton et al., April 26, 1994); U.S. Patent 5,305,514 (Letton et al., April 26, 1994); U.S. Patent 4,797,300 (Jandacek et al., issued January 10, 1989); US Patent 3,963,699 (Rizzi et al., issued June 15, 1976); US Patent 4,518,772 (Volpenhein, issued May 21, 1985); and US Patent 4,517,360 (Volpenhein, 1985 authorized on May 21).
适用于本发明的脂肪酸多元醇酯可通过本领域普通技术人员已知的各种方法进行制备。这些方法包括采用各种催化剂由多元醇与甲基、乙基或甘油脂肪酸酯进行酯交换;采用脂肪酰氯对多元醇进行酰化作用;采用脂肪酸酐对多元醇进行酰化作用;以及采用脂肪酸对多元醇进行酰化作用。例如可参见美国专利2,831,854;美国专利4,005,196(Jandacek,1977年1月25日授权)中所述的内容。Fatty acid polyol esters suitable for use in the present invention can be prepared by various methods known to those of ordinary skill in the art. These methods include transesterification of polyols with methyl, ethyl, or glycerol fatty acid esters using various catalysts; acylation of polyols with fatty acid chlorides; acylation of polyols with fatty acid anhydrides; Acylation of polyols. See, for example, US Patent 2,831,854; US Patent 4,005,196 (Jandacek, issued January 25, 1977).
特别优选的物质是INCI命名为聚棉籽油酸蔗糖酯的物质。其它皮肤有益成分A particularly preferred material is that which has the INCI designation polysucrose cottonseedoleate. Other Skin Benefits
本发明的组合物中可采用其它皮肤有益成分。可以用于本发明组合物的其它皮肤有益成分的实例包括:Other skin benefit ingredients may be employed in the compositions of the present invention. Examples of other skin benefit ingredients that may be used in the compositions of the present invention include:
(a)维生素化合物(a) vitamin compounds
本发明组合物中可含有维生素化合物、其前体及其衍生物。这些维生素化合物可以是天然形式,也可以是合成形式的。适用的维生素化合物包括:维生素A(例如,β-胡萝卜素、视黄酸、视黄醇、视黄醛衍生物(retinoids)、棕榈酸视黄醇酯、丙酸视黄醇酯等)、维生素B(例如,烟酸、烟酰胺、核黄素、泛酸等)、维生素C(例如,抗坏血酸等)、维生素D(例如,麦角甾醇、麦角钙化醇、胆钙化甾醇等)、维生素E(如乙酸生育酚等)以及维生素K(如,维生素K、甲萘醌、结核菌萘醌等)化合物。优选用于本发明组合物中的维生素化合物是维生素B3化合物。维生素B3化合物特别适用于调节皮肤状况,如WO-A-97/39733所述。如果使用维生素化合物,则本发明组合物中优选包含约0.01%(重量)至约50%(重量),更优选约为0.1%(重量)至约10%(重量),还更优选约为0.5%(重量)至约5%(重量)的维生素B3化合物。Vitamin compounds, their precursors and their derivatives may be included in the compositions of the present invention. These vitamin compounds can be in natural or synthetic form. Suitable vitamin compounds include vitamin A (e.g., beta-carotene, retinoic acid, retinol, retinoids, retinyl palmitate, retinyl propionate, etc.), vitamin B (such as niacin, niacinamide, riboflavin, pantothenic acid, etc.), vitamin C (such as ascorbic acid, etc.), vitamin D (such as ergosterol, ergocalciferol, cholecalciferol, etc.), vitamin E (such as acetic acid tocopherol, etc.) and vitamin K (eg, vitamin K, menadione, tuberculosis naphthoquinone, etc.) compounds. A preferred vitamin compound for use in the compositions of the present invention is a vitamin B3 compound. Vitamin B3 compounds are particularly useful for regulating skin condition as described in WO-A-97/39733. If vitamin compounds are used, the compositions of the present invention preferably comprise from about 0.01% by weight to about 50% by weight, more preferably from about 0.1% by weight to about 10% by weight, still more preferably from about 0.5 % (weight) to about 5% (weight) of vitamin B3 compounds.
用于本发明的术语“维生素B3化合物”是指如下式所示的化合物: The term "vitamin B3 compound" used in the present invention refers to a compound represented by the following formula:
其中R是-CONH2(即烟酰胺)、-COOH(即烟酸)或-CH2OH(即烟基醇(nicotinylalcohol));及其衍生物;以及上述化合物的盐。Wherein R is -CONH 2 (ie nicotinamide), -COOH (ie nicotinic acid) or -CH 2 OH (ie nicotinylalcohol); derivatives thereof; and salts of the above compounds.
上述维生素B3化合物的衍生物的实例包括:烟酸酯,包括烟酸的非血管扩张性酯;烟酰氨基酸、羧酸的烟基醇酯、烟酸N-氧化物和烟酰胺N-氧化物。Examples of derivatives of the aforementioned vitamin B3 compounds include: niacin esters, including non-vasodilatory esters of niacin; niacinamide, nicotinyl alcohol esters of carboxylic acids, niacin N-oxide, and niacinamide N-oxide thing.
合适的维生素B3化合物的实例是本领域熟知的,并且可购自多个来源,例如Sigma化学品公司(St.Louis,MO);ICN生物医学公司(Irvin,CA)和Aldrich化学品公司(Milwaukee,WI)。Examples of suitable vitamin B3 compounds are well known in the art and are commercially available from various sources such as Sigma Chemical Company (St. Louis, MO); ICN Biomedical Company (Irvin, CA) and Aldrich Chemical Company ( Milwaukee, WI).
维生素化合物可以基本纯品的形式加入,或以由天然来源(例如植物)经合适的物理和/或化学方法分离得到的提取物形式加入。(b)抗皱(anti-wrinkle)和抗皮肤萎缩(anti-skin atrophy)活性成分The vitamin compound may be added in substantially pure form, or as an extract obtained by suitable physical and/or chemical isolation from a natural source such as a plant. (b) Anti-wrinkle and anti-skin atrophy active ingredients
可用于本发明组合物中的抗皱和抗皮肤萎缩活性成分的实例包括:乳酸及其衍生物;视黄酸及其衍生物(例如顺式的和反式的);视黄醇;视黄基酯;烟酰胺;水杨酸及其衍生物;含硫的D和L氨基酸及其衍生物和盐,特别是N-乙酰基衍生物,其优选的实例是N-乙酰基-L-半胱氨酸;硫醇类,例如,乙硫醇;羟基酸;肌醇六磷酸;硫辛酸;溶血磷脂酸,以及去皮剂(skin peelagent)(例如,酚类等),但并非仅限于这些。(c)抗微生物和抗真菌活性成分Examples of anti-wrinkle and anti-skin atrophy active ingredients that may be used in the compositions of the present invention include: lactic acid and its derivatives; retinoic acid and its derivatives (e.g., cis and trans); retinol; retinyl Esters; Niacinamide; Salicylic acid and its derivatives; Sulfur-containing D and L amino acids and their derivatives and salts, especially N-acetyl derivatives, a preferred example of which is N-acetyl-L-cysteine amino acids; thiols such as ethanethiol; hydroxy acids; phytic acid; lipoic acid; (c) Antimicrobial and antifungal active ingredients
可以用于本发明组合物中的抗微生物和抗真菌活性成分的实例包括:β-内酰胺类药物、喹诺酮类药物、环丙氟哌酸、诺氟沙星、四环素、红霉素、丁胺卡那霉素、2,4,4′-三氯-2′-羟基二苯基醚、3,4,4′-三氯-N-碳酰苯胺、苯氧基乙醇、苯氧基丙醇、苯氧基异丙醇、多西环素、卷曲霉素、洗必太、金霉素、土霉素、氯林可霉素、乙胺丁醇(ethambutol)、羟乙磺酸己氧苯脒、甲硝唑、戊氧苯脒、庆大霉素、卡那霉素、林可霉素(lineomycin)、甲烯土霉素、乌洛托品、二甲胺四环素(minocycline)、新霉素、奈替米星、巴龙霉素、链霉素、妥布霉素、咪康唑、盐酸四环素、红霉素、红霉素锌、无味红霉素、红霉素硬脂酸酯、硫酸阿米卡星、盐酸多西环素、硫酸卷曲霉素、葡萄糖酸洗必太、盐酸洗必太、盐酸金霉素、盐酸土霉素、盐酸氯林可霉素、盐酸乙胺丁醇、盐酸甲硝唑、盐酸戊氧苯脒、硫酸庆大霉素、硫酸卡那霉素、盐酸林可霉素(lineomycin)、盐酸甲烯土霉素、马尿酸乌洛托品、孟德立胺(methenamine mandelate)、盐酸二甲胺四环素、硫酸新霉素、硫酸奈替米星、硫酸巴龙霉素、硫酸链霉素、硫酸妥布霉素、盐酸咪康唑、盐酸金刚烷胺(amanfadine hydrochloride)、硫酸金刚烷胺(amanfadine sulfate)、羟甲辛吡酮、对氯间二甲酚、制霉菌素、托萘酯(tolnaftate)、羟基吡啶硫酮锌(zinc pyrithione)和克霉唑。极性溶剂Examples of antimicrobial and antifungal active ingredients that may be used in the compositions of the present invention include: beta-lactams, quinolones, ciprofloxacin, norfloxacin, tetracycline, erythromycin, butylamine Kanamycin, 2,4,4'-trichloro-2'-hydroxydiphenyl ether, 3,4,4'-trichloro-N-carbanilide, phenoxyethanol, phenoxypropanol , phenoxyisopropanol, doxycycline, capreomycin, chlorhexidine, chlortetracycline, oxytetracycline, clindamycin, ethambutol (ethambutol), hexyl isethionate Amidine, metronidazole, pentamidine, gentamicin, kanamycin, lincomycin, methacycline, urotropine, minocycline, neomycin erythromycin, netilmicin, paromomycin, streptomycin, tobramycin, miconazole, tetracycline hydrochloride, erythromycin, erythromycin zinc, odorless erythromycin, erythromycin stearate, Amikacin sulfate, doxycycline hydrochloride, capreomycin sulfate, chlorhexidine gluconate, chlorhexidine hydrochloride, chlortetracycline hydrochloride, oxytetracycline hydrochloride, clincomycin hydrochloride, ethambutol hydrochloride , metronidazole hydrochloride, pentamidine hydrochloride, gentamicin sulfate, kanamycin sulfate, lincomycin hydrochloride (lineomycin), methacycline hydrochloride, urotropine hippurate, mendelidine ( methenamine mandelate), minocycline hydrochloride, neomycin sulfate, netilmicin sulfate, paromomycin sulfate, streptomycin sulfate, tobramycin sulfate, miconazole hydrochloride, amanfadine hydrochloride ), amanfadine sulfate, octopyrone, chloroxylenol, nystatin, tolnaftate, zinc pyrithione, and clotrimazole. polar solvent
本发明的组合物中还可以含有极性溶剂。任何适用在化妆品组合物中的极性溶剂均可以用在本发明中。但该极性溶剂所具有的极性应足以促进本发明中的小泡的形成。优选用于本发明组合物中的极性溶剂是水。Polar solvents may also be included in the compositions of the present invention. Any polar solvent suitable for use in cosmetic compositions may be used in the present invention. However, the polarity of the polar solvent should be sufficient to promote the formation of vesicles in the present invention. A preferred polar solvent for use in the compositions of the present invention is water.
本发明的组合物中优选含有10%(重量)-90%(重量),更优选为20%(重量)-80%(重量),还更优选为30%(重量)-60%(重量)的极性溶剂。增稠剂The composition of the present invention preferably contains 10% (weight)-90% (weight), more preferably 20% (weight)-80% (weight), still more preferably 30% (weight)-60% (weight) polar solvents. thickener
本发明组合物优选含有增稠剂。适用于化妆品组合物的任何增稠剂均可用于本发明。优选的增稠剂选自非离子水溶性聚合物、脂肪醇及其混合物。适用的非离子聚合物包括这样的水溶性聚合物,如纤维素醚(例如羟丁基甲基纤维素、羟丙基纤维素、羟丙基甲基纤维素、乙基羟乙基纤维素、经疏水改性的羟乙基纤维素和羟乙基纤维素)、聚(氧乙烯)、聚乙烯醇、聚乙烯基吡咯烷酮、羟丙基瓜耳胶、直链淀粉(amulose)、羟乙基直链淀粉(amylose)、淀粉和淀粉衍生物。适用的脂肪醇是具有以下通式的高分子量的、非挥发性的伯醇:The compositions of the invention preferably contain a thickener. Any thickener suitable for use in cosmetic compositions can be used in the present invention. Preferred thickeners are selected from nonionic water soluble polymers, fatty alcohols and mixtures thereof. Suitable nonionic polymers include such water-soluble polymers as cellulose ethers (e.g., hydroxybutylmethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, ethylhydroxyethylcellulose, hydrophobically Modified hydroxyethyl cellulose and hydroxyethyl cellulose), poly(oxyethylene), polyvinyl alcohol, polyvinylpyrrolidone, hydroxypropyl guar gum, amylose (amulose), hydroxyethyl linear Starch (amylose), starch and starch derivatives. Suitable fatty alcohols are high molecular weight, non-volatile primary alcohols having the general formula:
RCH2OHRCH 2 OH
其中R是C8-20烷基。它们可由天然油或脂制得,通过将脂肪酸中的-COOH羧基还原成羟基功能基而得到。或者,可由本领域已知的常规合成方法制备相同或类似结构的脂肪醇。合适的脂肪醇包括:二十二烷醇、C9-C11醇、C12-C13醇、C12-C15醇、C12-C16醇、C14-C15醇、辛醇、鲸蜡/硬脂醇、椰子油醇、癸醇、异鲸蜡醇、异硬脂醇、月桂醇、油醇、棕榈仁醇、硬脂醇、鲸蜡醇、牛油醇、十三烷醇或肉豆蔻醇,但并非只限于这些。其它任选成分Wherein R is C 8-20 alkyl. They can be obtained from natural oils or fats by reducing the -COOH carboxyl groups in fatty acids to hydroxyl functional groups. Alternatively, fatty alcohols of the same or similar structure can be prepared by conventional synthetic methods known in the art. Suitable fatty alcohols include: docosanol, C 9 -C 11 alcohols, C 12 -C 13 alcohols, C 12 -C 15 alcohols, C 12 -C 16 alcohols, C 14 -C 15 alcohols, octanol, Cetyl/Stearyl Alcohol, Coco Alcohol, Decyl Alcohol, Isocetyl Alcohol, Isostearyl Alcohol, Lauryl Alcohol, Oleyl Alcohol, Palm Kernel Alcohol, Stearyl Alcohol, Cetyl Alcohol, Tallow Alcohol, Tridecyl Alcohol or myristyl alcohol, but not limited to these. other optional ingredients
用在本发明方法中的组合物能够含有各种其它的任选组分。这些附加组分应是可药用的。按功能性分类,适用于本发明组合物中的成分的非限定性实例包括:磨料、吸收剂、抗痤疮活性成分、防结块剂、去头屑剂、抑汗剂、抗氧剂、抗病毒活性成分、人工晒黑活性成分和促进剂、生物添加剂、漂白剂、漂白活化剂、增白剂、增效助剂、缓冲剂、螯合剂、化学添加剂、着色剂、美容成分、清洁剂、化妆品用收敛剂、化妆品用杀菌剂、变性剂、除臭剂、脱皮活性成分、脱毛剂、药用收敛剂、染料、转染剂、酶、外用镇痛剂、发泡剂、矫味剂、成膜剂、香料组分、驱虫剂、防霉剂、非甾族抗炎活性成分、遮光剂、氧化染料、氧化剂、除虫成分、pH调节剂如柠檬酸、pH缓冲剂、药物活性成分、增塑剂、防腐剂、自由基清除剂、皮肤或毛发或指甲漂白剂、皮肤或毛发或指甲调理剂、皮肤或毛发或指甲渗透促进剂、稳定剂、表面活性剂、表面调理剂、还原剂、温度抑制剂、粘度调节剂以及增温剂如发热沸石。适用于此的美学组分(aesthetic components)如:着色剂、香精油和皮肤愈合剂。其它适用于此的任选物质包括:颜料。适用于本发明组合物的颜料可以是有机和/或无机成分。在术语颜料范围内的还有低着色或低光泽物质,如亚光涂饰剂(matte finishing agents),以及光散射剂。适用的颜料的实例有氧化铁、酰基谷氨酸氧化铁、二氧化钛、群青、D&C染料、胭脂虫红及其混合物。配制步骤The compositions used in the methods of the present invention can contain various other optional components. These additional components should be pharmaceutically acceptable. Non-limiting examples of ingredients suitable for use in the compositions of the present invention, classified by function, include: abrasives, absorbents, anti-acne actives, anti-caking agents, anti-dandruff agents, antiperspirants, antioxidants, anti-acne Viral active ingredients, artificial tanning active ingredients and accelerators, biological additives, bleaching agents, bleach activators, brighteners, builders, buffers, chelating agents, chemical additives, coloring agents, cosmetic ingredients, cleaning agents, Astringents for cosmetics, bactericides for cosmetics, denaturants, deodorants, peeling active ingredients, depilatory agents, medicinal astringents, dyes, transfection agents, enzymes, topical analgesics, foaming agents, flavoring agents, Film formers, fragrance components, insect repellants, antifungal agents, non-steroidal anti-inflammatory active ingredients, sunscreens, oxidation dyes, oxidizing agents, insecticidal ingredients, pH regulators such as citric acid, pH buffers, pharmaceutical active ingredients , plasticizers, preservatives, free radical scavengers, skin or hair or nail bleaching agents, skin or hair or nail conditioners, skin or hair or nail penetration enhancers, stabilizers, surfactants, surface conditioners, reducing additives, temperature depressants, viscosity regulators and warming agents such as heating zeolites. Aesthetic components suitable for use here are: colorants, essential oils and skin healing agents. Other optional materials suitable for use herein include: Pigments. Pigments suitable for use in the compositions of the present invention may be organic and/or inorganic components. Also within the scope of the term pigment are low-pigmentation or low-gloss substances, such as matte finishing agents, and light scattering agents. Examples of suitable pigments are iron oxides, iron oxides acyl glutamate, titanium dioxide, ultramarine blue, D&C dyes, cochineal and mixtures thereof. Preparation steps
优选本发明的组合物以季铵化合物可形成小泡的方式制备。优选所述小泡中还含有保湿剂。优选,所述小泡中还包含润肤剂。还更优选,所述的小泡包含防晒活性物质。为确保最佳性能特征,优选本发明组合物由以下步骤制备:Preferably the compositions of the present invention are prepared in such a way that the quaternary ammonium compound can form vesicles. Preferably, the vesicles also contain a humectant. Preferably, the vesicles also contain an emollient. Still more preferably, said vesicles comprise sunscreen actives. To ensure optimum performance characteristics, it is preferred that the compositions of the present invention are prepared by:
(i)在高于季铵成分熔点的温度下将全部或部分季铵成分与保湿剂、水溶性防晒活性成分、水溶性护肤活性成分(如果包含的话)和优选还有极性溶剂相互混和;(i) intermixing all or part of the quaternary ammonium ingredient with the humectant, water-soluble sunscreen active, water-soluble skin care active (if included) and preferably also a polar solvent at a temperature above the melting point of the quaternary ammonium ingredient;
(ii)该混合物任选经剧烈搅拌;(ii) the mixture is optionally vigorously stirred;
(iii)在另一单独容器中按如下方法制备乳剂:在高于季铵成分熔点的温度下将含润肤剂的油相、有关的增稠剂(只要所述的增稠剂是油溶性的)、油溶性防晒活性成分和任何剩余的季铵成分相混合。单独制备水相。将水、有关的增稠剂(只要所述的增稠剂是水溶性的)和其它剩余的水溶性成分加热至与油相相同的温度下。(iii) In a separate container, an emulsion is prepared by mixing the oily phase containing the emollient, the associated thickener (so long as said thickener is oil-soluble) at a temperature above the melting point of the quaternary ammonium ingredient, ), the oil-soluble sunscreen active, and any remaining quaternary ammonium ingredients. Prepare the aqueous phase separately. Water, associated thickeners (so long as said thickeners are water soluble) and other remaining water soluble ingredients are heated to the same temperature as the oil phase.
(iv)将乳液的油相和水相的温度大约平衡,然后在搅拌条件下将水相与油相相结合。(iv) The temperature of the oil phase and the water phase of the emulsion is approximately balanced, and then the water phase is combined with the oil phase under stirring conditions.
(v)在制备乳剂时,将步骤(i)中制成的混合物经搅拌加入上述乳液中。(v) When preparing the emulsion, the mixture prepared in step (i) is added to the above emulsion with stirring.
使用方法Instructions
本发明的化妆品组合物可以常规的方式使用用于护理皮肤。将有效量的组合物,通常为约0.1克至约50克,优选约1克至约20克涂抹到湿或干,优选湿的皮肤上。组合物的应用通常包括将组合物在皮肤上揉抹,通常是用手和手指进行。然后将组合物留在皮肤上,或者,优选对皮肤进行漂洗。The cosmetic compositions according to the invention can be used in conventional manner for the care of the skin. An effective amount of the composition, usually from about 0.1 gram to about 50 grams, preferably from about 1 gram to about 20 grams, is applied to wet or dry, preferably wet, skin. Application of the composition generally involves rubbing the composition on the skin, usually with the hands and fingers. The composition is then left on the skin, or, preferably, the skin is rinsed.
因此,护理皮肤的优选的方法包括下列步骤:Therefore, a preferred method of caring for the skin comprises the following steps:
(a)将有效量的化妆品组合物施用到皮肤上,(a) applying an effective amount of the cosmetic composition to the skin,
(b)漂洗皮肤。(b) Rinse the skin.
本发明的优选的方面涉及上述方法,包括在将组合物应用到湿皮肤上之前,将组合物施用到干皮肤上。因此,优选的方法包括:A preferred aspect of the invention relates to the above method comprising applying the composition to dry skin prior to applying the composition to wet skin. Therefore, preferred methods include:
(i)将有效量的化妆品组合物施用于干皮肤上;(i) applying an effective amount of the cosmetic composition to dry skin;
(ii)在淋浴(shower)下漂洗皮肤;(ii) rinsing the skin under a shower;
(iii)再次使用所述的组合物;以及(iii) reusing said composition; and
(iv)再次漂洗。(iv) Rinse again.
多数对人体皮肤的损伤是由在清洗过程中皮肤重复多次暴露于含表面活性剂的组合物而产生的。现已发现能够使用本发明的方法缓解这种损伤。因此另一优选方法包括:Most damage to human skin results from repeated exposure of the skin to surfactant-containing compositions during cleansing. It has now been found that this damage can be alleviated using the methods of the present invention. Another preferred method therefore includes:
(i)采用含表面活性剂的组合物清洗皮肤;(i) cleansing the skin with a surfactant-containing composition;
(ii)漂洗皮肤;(ii) rinsing the skin;
(iii)将本发明的组合物用于湿皮肤上;(iii) applying the composition of the invention to wet skin;
(iv)漂洗皮肤。(iv) Rinse the skin.
现在还发现本发明的组合物在作为常规的清洗程序的部分而引入时,特别适用。因此另一优选方法包括:It has also now been found that the compositions of the present invention are particularly useful when incorporated as part of a regular cleaning routine. Another preferred method therefore includes:
(i)在皮肤上应用包含下列的组合物:(i) applying to the skin a composition comprising:
(a)至少一种季铵化合物;(a) at least one quaternary ammonium compound;
(b)保湿剂;和(b) humectants; and
(ii)漂洗皮肤;(ii) rinsing the skin;
(iii)在48小时内重复步骤(i)和(ii)。(iii) Repeat steps (i) and (ii) within 48 hours.
本发明的组合物还可以用于缓解因皮肤暴露于紫外线辐射而引起的损伤、在游泳或类似的水中运动中皮肤与水接触引起的损伤、剃须或剥离引起的损伤或者在洗浴时皮肤与水接触造成的皮肤损伤。The composition of the present invention may also be used to alleviate damage caused by exposure of the skin to ultraviolet radiation, damage caused by contact of the skin with water during swimming or similar water sports, damage caused by shaving or exfoliation, or damage caused by skin contact with the skin while bathing. Skin damage from water contact.
实施例Example
以下实施例用于进一步说明本发明范围内的优选实施方案。所列实施例仅用于说明,而对本发明不构成任何限定,在不背离本发明的精神或范围的情况下存在多种变化方式。除非特别指出,所有成分均以活性成分的重量百分比计。
1:购自Croda1: Purchased from Croda
2:购自Floratech,AZ,USA2: Purchased from Floratech, AZ, USA
3:购自Hoffman La Roche,NJ,USA3: Purchased from Hoffman La Roche, NJ, USA
4:购自Amerchol,NJ,USA4: Purchased from Amerchol, NJ, USA
5:购自Rhodia,NJ,USA注释5: Purchased from Rhodia, NJ, USA Notes
·实施例1,4,7,9,17,20,22,24,28,36,38,47,49,53,56中,所用的季铵化合In embodiment 1,4,7,9,17,20,22,24,28,36,38,47,49,53,56, the quaternary ammonium compound used
物是二硬脂基二甲基氯化铵,购自Goldschmidt,商品名为VarisoftThe compound is distearyldimethylammonium chloride, available from Goldschmidt under the trade name Varisoft
TA100TA100
·实施例2,3,5,6,8,10,15,16,18,19,21,23,26,27,31,33,34,35,37,Examples 2, 3, 5, 6, 8, 10, 15, 16, 18, 19, 21, 23, 26, 27, 31, 33, 34, 35, 37,
41,45,46,48,50,51,52,54,55中,所用的季铵化合物是N,N-二(低芥酸41, 45, 46, 48, 50, 51, 52, 54, 55, the quaternary ammonium compound used is N, N-di(lowerucic acid
菜子酰基-氧-乙基)-N-甲基,N-(2-羟乙基)甲基硫酸铵,购自Goldschmidt,Brassinoyl-oxy-ethyl)-N-methyl, N-(2-hydroxyethyl)ammonium methylsulfate was purchased from Goldschmidt,
商品名为Rewoquat V3620。The trade name is Rewoquat V3620.
·实施例11中,所用的季铵化合物是N,N-二(低芥酸菜子酰基-氧-乙In Example 11, the quaternary ammonium compound used is N, N-bis(lowerucinoyl-oxygen-ethyl
基)-N-甲基,N-(2-羟乙基)甲基硫酸铵,购自Goldschmidt,商品名为base)-N-methyl, N-(2-hydroxyethyl)ammonium methylsulfate, purchased from Goldschmidt under the trade name
Rewoquat WE18Rewoquat WE18
·实施例12中,所用的季铵化合物是N,N-二(低芥酸菜子酰基-氧-乙In Example 12, the quaternary ammonium compound used is N, N-di(lowerucicanoyl-oxygen-ethyl
基)-N-甲基,N-(2-羟乙基)氯化铵,购自Goldschmidt,开发材料(WE25)base)-N-methyl, N-(2-hydroxyethyl)ammonium chloride, available from Goldschmidt, development material (WE25)
·实施例13中,所用的季铵化合物是甲基双(氢化牛油酰氨基乙基)(2-In Example 13, the quaternary ammonium compound used is methyl bis (hydrogenated tallow amido ethyl) (2-
羟乙基)甲基硫酸铵,购自Goldschmidt,商品名为Varisoft 110Hydroxyethyl) ammonium methyl sulfate, purchased from Goldschmidt, trade name is Varisoft 110
·实施例14中,所用的季铵化合物是甲基双(牛油酰氨基乙基)(2-羟乙基)In Example 14, the quaternary ammonium compound used is methyl bis(tallowamidoethyl) (2-hydroxyethyl)
甲基硫酸铵,购自Goldschmidt,商品名为Varisoft 222Ammonium methylsulfate available from Goldschmidt under the tradename Varisoft 222
·实施例25中,所用的季铵化合物是甲基-1-牛油酰乙基-2-牛油咪唑啉,In Example 25, the quaternary ammonium compound used is methyl-1-tallowoyl ethyl-2-tallow imidazoline,
购自Goldschmidt,开发材料Purchased from Goldschmidt, Development Materials
·实施例29中,所用的季铵化合物是甲基-1-牛油酰氨基乙基-2-牛油咪In Example 29, the quaternary ammonium compound used is methyl-1-tallowamidoethyl-2-tallow
唑啉,购自Goldschmidt,开发材料Oxazoline, purchased from Goldschmidt, Development Materials
·实施例30中,所用的季铵化合物是甲基-1-牛油酰乙基-2-牛油咪唑啉In Example 30, the quaternary ammonium compound used is methyl-1-tallowoyl ethyl-2-tallow imidazoline
鎓甲基硫酸盐,购自Goldschmidt,Onium methylsulfate, available from Goldschmidt,
·实施例32中,所用的季铵化合物是甲基-1-牛油酰氨基乙基-2-牛油咪In Example 32, the quaternary ammonium compound used is methyl-1-tallowamidoethyl-2-tallow
唑啉鎓甲基硫酸盐,购自Goldschmidt,商品名为Varisoft 475,Varisoft 445Azolinium methylsulfate available from Goldschmidt under the trade names Varisoft 475, Varisoft 445
·实施例39中,所用的季铵化合物是N,N-二甲基-N-(低芥酸菜子酰基-In Example 39, the quaternary ammonium compound used is N, N-dimethyl-N-(canolacoyl-
氧-乙基)-N-(低芥酸菜子酰基酰氨基乙基)胺,购自Kao。Oxy-ethyl)-N-(canolaloylamidoethyl)amine was purchased from Kao.
·实施例40中,所用的季铵化合物是N,N-二甲基-N(低芥酸菜子酰基-In Example 40, the quaternary ammonium compound used is N, N-dimethyl-N (canolanoyl-
氧-乙基)-N-(低芥酸菜子酰基酰氨基乙基)甲基硫酸铵,购自KaoOxy-ethyl)-N-(canolaloylamidoethyl)ammonium methylsulfate was purchased from Kao
·实施例42中,所用的季铵化合物是N,N′-双(2-牛油酰基氧乙基)-N,N,In Example 42, the quaternary ammonium compound used is N, N'-bis(2-tallowoyloxyethyl)-N, N,
N′,N′-四亚甲基二氯二铵,披露于美国专利4728337、美国专利4721512、N', N'-tetramethylene diammonium dichloride, disclosed in U.S. Patent 4728337, U.S. Patent 4721512,
美国专利4906413中,购自Ciba-Geigy公司Available from Ciba-Geigy in US Patent 4906413
·实施例43中,所用的季铵化合物是N,N′-双(2-低芥酸菜子酰基氧乙In Example 43, the quaternary ammonium compound used is N, N'-bis (2-lowerucinoyloxyethyl
基)-N,N′-二甲基-N,N′-(2-羟乙基)-1,6-己烷甲基硫酸二铵,披露于base)-N,N'-dimethyl-N,N'-(2-hydroxyethyl)-1,6-hexane diammonium methyl sulfate, disclosed in
Goldschmidt-Witco的专利EP0503155A1和EP0803498中Goldschmidt-Witco patents EP0503155A1 and EP0803498
·实施例44中,所用的季铵化合物是由脂肪酸、二官能团(或官能团)酸In embodiment 44, the quaternary ammonium compound used is made of fatty acid, two functional group (or functional group) acid
和三乙醇胺反应、然后经季铵化得到的二聚和低聚酯类季铵化合物Reaction with triethanolamine followed by quaternization of dimeric and oligoester quaternary ammonium compounds
(quats),披露于WO98/49132(Kao)和美国专利5880289(Henkel)中。方法适用于包括组分C的实施例:(quats), disclosed in WO98/49132 (Kao) and US Patent 5880289 (Henkel). The method is applicable to the examples including component C:
1.预混物1:在高于选定的季铵化合物的转化温度的条件下混和A组中的各组分,保留预定量的季铵化合物和水不加入。剧烈搅拌该预混物。1. Premix 1: Mix the components of Group A above the conversion temperature of the selected quaternary ammonium compound, leaving the predetermined amount of quaternary ammonium compound and water unadded. The premix was stirred vigorously.
2.预混物2:将B和C组中的各组分与未用在预混物1中的剩余的季铵化合物和水混和。加热至季铵化合物和油类的熔点以上。2. Premix 2: Combine the components of Groups B and C with the remaining quaternary ammonium compound not used in Premix 1 and water. Heat above the melting point of quaternary ammonium compounds and oils.
3.将预混物1和2混和,并冷却至40℃,搅拌加入香精。适用于包括组分D的实施例:3. Mix premix 1 and 2, cool to 40°C, stir and add essence. Applicable to examples including Component D:
1.预混物1:在高于选定的季铵化合物的转化温度的条件下混和A组中的各组分,保留预定量的水不加入。剧烈搅拌该预混物。1. Premix 1: Mix the components of Group A above the conversion temperature of the selected quaternary ammonium compound, leaving the predetermined amount of water unadded. The premix was stirred vigorously.
2.预混物2:搅拌下,将D组中的各组分与未用在预混物1中的剩余的水混和。2. Premix 2: Under agitation, combine the ingredients in Group D with the remaining water not used in Premix 1.
3.将预混物1和2、以及B和E组中的各组分混和。剧烈搅拌。3. Combine the components of Premixes 1 and 2, and Groups B and E. Stir vigorously.
上述实施例中的组合物提供良好的护肤益处,如良好的滋润作用、良好的水合作用、良好的皮肤感、良好的皮肤柔软感和/或良好的皮肤光滑感,同时具有低程度的不利作用如油腻性、粘着性或粘腻性。The compositions of the above examples provide good skin care benefits, such as good moisturization, good hydration, good skin feel, good skin softness and/or good skin smoothness, while having a low degree of adverse Effects such as greasiness, stickiness or stickiness.
Claims (10)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9915094.8A GB9915094D0 (en) | 1999-06-28 | 1999-06-28 | Cosmetic compositions |
| GB9915095.5 | 1999-06-28 | ||
| GBGB9915095.5A GB9915095D0 (en) | 1999-06-28 | 1999-06-28 | Cosmetic compositions |
| GB9915094.8 | 1999-06-28 | ||
| US20179800P | 2000-05-04 | 2000-05-04 | |
| US60/201,798 | 2000-05-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1371274A true CN1371274A (en) | 2002-09-25 |
Family
ID=27269756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN00812232A Pending CN1371274A (en) | 1999-06-28 | 2000-06-27 | Cosmetic composition |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1189590A1 (en) |
| JP (1) | JP2003503335A (en) |
| KR (1) | KR20020012003A (en) |
| CN (1) | CN1371274A (en) |
| AU (1) | AU5769900A (en) |
| BR (1) | BR0011980A (en) |
| CA (1) | CA2376807A1 (en) |
| CZ (1) | CZ20014705A3 (en) |
| MX (1) | MXPA02000481A (en) |
| WO (1) | WO2001000161A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101185622B (en) * | 2007-07-16 | 2011-05-04 | 孙敏 | Oil-controlling, anti-blackening and skin-whitening cream |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10132174A1 (en) * | 2001-07-03 | 2003-03-27 | Goldschmidt Ag Th | New betaine ester compounds are useful in hair and skin care products and in cleaning agents |
| EP1406584A1 (en) * | 2001-07-13 | 2004-04-14 | The Procter & Gamble Company | Mousse forming compositions comprising quaternary ammonium agents |
| DE102006015753A1 (en) * | 2006-04-04 | 2007-10-11 | Goldschmidt Gmbh | Use of esterquats in compositions as sand-repellent substances |
| US9549891B2 (en) | 2012-03-19 | 2017-01-24 | The Procter & Gamble Company | Superabsorbent polymers and sunscreen actives for use in skin care compositions |
| KR102043535B1 (en) | 2015-06-29 | 2019-11-11 | 더 프록터 앤드 갬블 캄파니 | Superabsorbent polymers and starch powders for use in skin care compositions |
| US10035970B2 (en) | 2016-05-09 | 2018-07-31 | Basf Se | Friction-reducing compound, method of producing same, and lubricant composition |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2095607C (en) * | 1990-11-30 | 1997-10-14 | Deborah J. Turner | Leave-on facial emulsion compositions |
| EP0748202B1 (en) * | 1994-03-04 | 2001-09-26 | Unilever Plc | Liposomes for deposition on hair |
| DE19538094C1 (en) * | 1995-10-13 | 1997-02-20 | Kao Corp Gmbh | Use of an aqueous emulsion or dispersion as a hair care product |
| FR2741263B1 (en) * | 1995-11-22 | 1997-12-26 | Oreal | COMPOSITION COMPRISING AN AQUEOUS DISPERSION OF LIPID VESICLES ENCAPSULATING AN ACID-FUNCTIONAL UV FILTER AND USES FOR TOPICAL APPLICATION |
| CA2265769C (en) * | 1996-09-19 | 2007-10-16 | The Procter & Gamble Company | Concentrated quaternary ammonium fabric softener compositions containing cationic polymers |
| AU737316B2 (en) * | 1997-05-30 | 2001-08-16 | Shiseido Company Ltd. | Gelling agent and gel compositions |
| US6043204A (en) * | 1997-11-07 | 2000-03-28 | Kaufman; Stacy R. | Body cleansing composition providing protection against sunburn after rinsing |
-
2000
- 2000-06-27 CN CN00812232A patent/CN1371274A/en active Pending
- 2000-06-27 WO PCT/US2000/017631 patent/WO2001000161A1/en not_active Ceased
- 2000-06-27 EP EP00943191A patent/EP1189590A1/en not_active Withdrawn
- 2000-06-27 AU AU57699/00A patent/AU5769900A/en not_active Abandoned
- 2000-06-27 JP JP2001505874A patent/JP2003503335A/en not_active Withdrawn
- 2000-06-27 CZ CZ20014705A patent/CZ20014705A3/en unknown
- 2000-06-27 CA CA002376807A patent/CA2376807A1/en not_active Abandoned
- 2000-06-27 KR KR1020017016863A patent/KR20020012003A/en not_active Ceased
- 2000-06-27 BR BR0011980-6A patent/BR0011980A/en not_active IP Right Cessation
- 2000-06-27 MX MXPA02000481A patent/MXPA02000481A/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101185622B (en) * | 2007-07-16 | 2011-05-04 | 孙敏 | Oil-controlling, anti-blackening and skin-whitening cream |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003503335A (en) | 2003-01-28 |
| WO2001000161A1 (en) | 2001-01-04 |
| KR20020012003A (en) | 2002-02-09 |
| AU5769900A (en) | 2001-01-31 |
| BR0011980A (en) | 2002-03-12 |
| MXPA02000481A (en) | 2002-07-02 |
| EP1189590A1 (en) | 2002-03-27 |
| CZ20014705A3 (en) | 2002-05-15 |
| CA2376807A1 (en) | 2001-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1313068C (en) | Rinsable skin conditioning compositions | |
| CN1158065C (en) | Photoprotective compositions | |
| CN1100532C (en) | Anti-dandruff composition comprising salicylic acid and zwitterionic compound | |
| CN1261780A (en) | Skin care compositions comprising vitamin B3 and preservative | |
| JP2004536839A (en) | Mousse-forming compositions containing quaternary ammonium agents | |
| CN1536984A (en) | Topical compositions comprising activated trans-structured cosmetic bonding agents | |
| CN1371274A (en) | Cosmetic composition | |
| CN1535136A (en) | Topical compositions comprising functionalized anhydride-based cosmetic bonding agents | |
| CN1371273A (en) | Cosmetic composition containing quaternary ammonium compound and tocopherol | |
| CN1371272A (en) | Cosmetic composition containing pantothenic acid | |
| CN1355689A (en) | Methods for regulating condition of mammalian keratinous tissue | |
| CN1371267A (en) | Cosmetic composition | |
| CN1496250A (en) | Topical composition comprising a diazonium salt-based cosmetic bonding agent | |
| WO2001000158A1 (en) | Cosmetic compositions containing quaternary ammonium compounds | |
| CN1371271A (en) | Cosmetic composition | |
| CN1371270A (en) | Beauty method | |
| CN1527696A (en) | Mousse-forming compositions comprising quaternary ammonium agents | |
| WO2001000172A1 (en) | Cosmetic compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |